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Supplementary Methods
Samples were fragmented using a Bioruptor (Diagenode, Liège, Belgium), indexed for multiplexing and hybridised (in pools of 12 samples)
according to the manufacturer's instructions. Sequencing was performed with an Illumina HiSeq 2000 (Illumina, San Diego, CA, USA) (48 samples per lane) and 100 bp paired end reads. The resulting reads were aligned with BWA and duplicates were removed with Picard. We then applied GATK indel realignment, and performed SNV and INDEL discovery and genotyping using GATK UnifiedGenotyper with standard hard filtering parameters according to GATK Best Practices recommendations 84 . Variants were annotated with ANNOVAR and pathogenic mutations located within 50 bp upstream and 50 bp downstream of each exon were identified.
As previously described 85 , for the 21 genes for which testing is available in the Exeter laboratory by Sanger sequencing, the average depth of coverage was over 250 reads and >99% of bases had a minimum read depth of 30. Two specific regions of low coverage (<20 reads)
were observed across two ~300bp GC-rich regions in the exon 2 of GATA6 and GATA4. In patients for whom these regions were not sufficiently covered and no pathogenic mutation was identified, Sanger sequencing of the specific exon 2 amplicons were carried out in patients with congenital features suggestive of a GATA6/GATA4 mutation (e.g. low birth weight, exocrine insufficiency, congenital heart malformation). Two positive controls (for a known heterozygous deletion and a known insertion) were included in each 48 sample batch to verify the ability to detect deletions/insertions.
